Volume : 10, Issue : 05, May – 2023
Title:
39.REVIEW OF COMMON DENTAL PROBLEMS AND USE OF DIFFERENT HERBAL FORMULATIONS
Authors :
Sagar Gour Mondal, Aamani D. Meesala
Abstract :
The oral cavity is part of the digestive system, which is composed of many important anatomical structures, including teeth, periodontal tissues, oral mucosa, maxillary and mandibular bones, as well as other soft and hard tissues. It is also a complex ecological niche as more than 700 microorganism species colonize the oral cavity, which is closely associated with oral health . The oral microbiota could help prevent pathogenic microorganisms from growing and help to maintain the stability and balance of oral microecology. However, the composition of oral microbiota could alter due to the change of diet, poor oral hygiene, systemic diseases, etc., which might lead to the dysbiosis of oral microecology, and thus many oral microbiota related diseases, i.e., oral infectious diseases. It has been widely considered that oral infectious diseases such as dental caries, periodontitis, peri-implantitis, and oral candidiasis are caused by microbial dysbiosis instead of specific kinds of bacteria. Furthermore, it has been gradually recognized that oral health is closely related to systemic health. Therefore, great effort has been made for the treatment and prevention of oral infectious diseases. Drug therapy plays an important role in the inhibition of bacterial growth and inflammatory response, and thus the promotion of tissue regeneration. Systemic administration and local drug delivery are both important ways for drug administration. However, systemic administration could cause many other problems.
Keywords: Dental Caries, Oral Lesion, Gingivitis, Chewing Tablets.
Cite This Article:
Please cite this article in press Sagar Gour Mondal et al, Review Of Common Dental Problems And Use Of Different Herbal Formulations., Indo Am. J. P. Sci, 2023; 10 (05).
Number of Downloads : 10
References:
1. Scannapieco, F.A. The oral microbiome: Its role in health and in oral and systemic infections. Clin. Microbiol. Newsl. 2013, 35, 163–169. [CrossRef]
2. Zarco, M.F.; Vess, T.J.; Ginsburg, G.S. The oral microbiome in health and disease and the potential impact on personalized dental medicine. Oral Dis. 2012, 18, 109–120. [CrossRef]
3. W.H. Organization, Oral Health. Fact Sheet N 318, World Health Organization, Geneva (CH), 2012.
4. V. Sankar, V. Hearnden, K. Hull, D.V. Juras, M. Greenberg, A. Kerr, P.B. Lockhart, L.L. Patton, S. Porter, M. Thornhill, Local drug delivery for oral mucosal diseases: challenges and opportunities, Oral Dis. 17 (s1) (2011) 73–84.
5. R.A. Bagramian, F. Garcia-Godoy, A.R. Volpe, The global increase in dental caries. A pending public health crisis, Am. J. Dent. 22 (1) (2009) 3–8.
6. R.H. Selwitz, A.I. Ismail, N.B. Pitts, Dental caries, Lancet 369 (9555) (2007) 51–59.
7. D.L. Ozsvath, Fluoride and environmental health: a review, Rev. Environ. Sci. Biol./ Technol. 8 (1) (2009) 59–79.
8. B. Mizrahi, A.J. Domb, Mucoadhesive polymers for delivery of drugs to the oral cavity, Recent. Patents Drug. Deliv. Formul. 2 (2) (2008) 108–119.
9. T. Walsh, H. Worthington, A. Glenny, P. Appelbe, V. Marinho, X. Shi, Fluoride toothpastes of different concentrations for preventing dental caries in children and adolescents, Cochrane Database Syst. Rev. 20 (1) (2010) CD007868.
10. K. Toumba, M. Curzon, A clinical trial of a slow-releasing fluoride device in children, Caries Res. 39 (3) (2005) 195–200.
11. S.M. Dizaj, M. Barzegar-Jalali, M.H. Zarrintan, K. Adibkia, F. Lotfipour, Calcium carbonate nanoparticles; Potential in bone and tooth disorders, Pharm. Sci. 20 (2015) 175–182.
12. F. Parnia, J. Yazdani, V. Javaherzadeh, S.M. Dizaj, Overview of nanoparticle coating of dental implants for enhanced osseointegration and antimicrobial purposes, J. Pharm. Pharm. Sci. 20 (2017) 148–160.
13. Gokdogan O, Catli T, Ileri F. Halitosis in otorhinolaryngology practice. Iran J Otorhinolaryngol. 2015;27:145–53.
14. Bollen CM, Beikler T. Halitosis: The multidisciplinary approach. Int J Oral Sci. 2012;4:55–63.
15. Basavaraj P, Nitin K. Halitosis: A review. Indian J Stomatol. 2011;2:183–6.
16. Hughes FJ, McNab R. Oral malodour–a review. Arch Oral Biol. 2008;53(Suppl 1):S1–7.
17. Nogueira-Filho GR, Duarte PM, Toledo S, Tabchoury CP, Cury JA. Effect of triclosan dentifrices on mouth volatile sulphur compounds and dental plaque trypsin-like activity during experimental gingivitis development. J Clin Periodontol. 2002;29:1059–64.
18. Tonzetich J. Oral malodour: An indicator of health status and oral cleanliness. Int Dent J. 1978;28:309–19.
19. Armstrong BL, Sensat ML, Stoltenberg JL. Halitosis: A review of current literature. J Dent Hyg. 2010;84:65–74.
20. Sopapornamorn P, Ueno M, Shinada K, Yanagishita M, Kawaguchi Y. Relationship between total salivary protein content and volatile sulfur compounds levels in malodor patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:655–60.
21. https://www.mayoclinic.org/diseases-conditions/gingivitis/symptoms-causes/syc-20354453
22. Listgarten MA. Nature of periodontal diseases: Pathogenic mechanisms. J Periodontal Res. 1987;22:172–8.
23. Heasman PA, Hughes FJ. Drugs, medications and periodontal disease. Br Dent J. 2014;217:411–
24. Deasy PB, Collins AE, MacCarthy DJ, Russell RJ. Use of strips containing tetracycline hydrochloride or metronidazole for the treatment of advanced periodontal disease. J Pharm Pharmacol. 1989;41:694–9.